NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,588,000 | +45.3% | 136,765 | +1.0% | 1.03% | +32.5% |
Q4 2018 | $4,533,000 | -37.0% | 135,394 | -1.4% | 0.78% | -23.8% |
Q3 2018 | $7,193,000 | +82.1% | 137,267 | +8.8% | 1.02% | +76.0% |
Q2 2018 | $3,950,000 | +69.2% | 126,194 | +17.9% | 0.58% | +68.6% |
Q1 2018 | $2,334,000 | – | 107,051 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |